drugset / Trial / NCT00314171

A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

NCT00314171

Phase 3 Completed 437 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2005-10
Primary completion
2007-08
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Brinzolamide Small molecule 10 mg/ml Topical
Comparator Dorzolamide Small molecule 20 mg/ml Topical
Comparator Timolol Other / unclassified 5 mg/ml Topical